Literature DB >> 24063316

CXCR3 ligands are associated with the continuum of diffuse alveolar damage to chronic lung allograft dysfunction.

Michael Y Shino1, S Samuel Weigt, Ning Li, Vyacheslav Palchevskiy, Ariss Derhovanessian, Rajan Saggar, David M Sayah, Aric L Gregson, Michael C Fishbein, Abbas Ardehali, David J Ross, Joseph P Lynch, Robert M Elashoff, John A Belperio.   

Abstract

RATIONALE: After lung transplantation, insults to the allograft generally result in one of four histopathologic patterns of injury: (1) acute rejection, (2) lymphocytic bronchiolitis, (3) organizing pneumonia, and (4) diffuse alveolar damage (DAD). We hypothesized that DAD, the most severe form of acute lung injury, would lead to the highest risk of chronic lung allograft dysfunction (CLAD) and that a type I immune response would mediate this process.
OBJECTIVES: Determine whether DAD is associated with CLAD and explore the potential role of CXCR3/ligand biology.
METHODS: Transbronchial biopsies from all lung transplant recipients were reviewed. The association between the four injury patterns and subsequent outcomes were evaluated using proportional hazards models with time-dependent covariates. Bronchoalveolar lavage (BAL) concentrations of the CXCR3 ligands (CXCL9/MIG, CXCL10/IP10, and CXCL11/ITAC) were compared between allograft injury patterns and "healthy" biopsies using linear mixed-effects models. The effect of these chemokine alterations on CLAD risk was assessed using Cox models with serial BAL measurements as time-dependent covariates.
MEASUREMENTS AND MAIN RESULTS: There were 1,585 biopsies from 441 recipients with 62 episodes of DAD. An episode of DAD was associated with increased risk of CLAD (hazard ratio, 3.0; 95% confidence interval, 1.9-4.7) and death (hazard ratio, 2.3; 95% confidence interval, 1.7-3.0). There were marked elevations in BAL CXCR3 ligand concentrations during DAD. Furthermore, prolonged elevation of these chemokines in serial BAL fluid measurements predicted the development of CLAD.
CONCLUSIONS: DAD is associated with marked increases in the risk of CLAD and death after lung transplantation. This association may be mediated in part by an aberrant type I immune response involving CXCR3/ligands.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24063316      PMCID: PMC3863740          DOI: 10.1164/rccm.201305-0861OC

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  46 in total

1.  The Registry of the International Society for Heart and Lung Transplantation: Twenty-eighth Adult Lung and Heart-Lung Transplant Report--2011.

Authors:  Jason D Christie; Leah B Edwards; Anna Y Kucheryavaya; Christian Benden; Fabienne Dobbels; Richard Kirk; Axel O Rahmel; Josef Stehlik; Marshall I Hertz
Journal:  J Heart Lung Transplant       Date:  2011-10       Impact factor: 10.247

2.  Aspergillus colonization of the lung allograft is a risk factor for bronchiolitis obliterans syndrome.

Authors:  S S Weigt; R M Elashoff; C Huang; A Ardehali; A L Gregson; B Kubak; M C Fishbein; R Saggar; M P Keane; R Saggar; J P Lynch; D A Zisman; D J Ross; J A Belperio
Journal:  Am J Transplant       Date:  2009-05-13       Impact factor: 8.086

3.  Combined CMV prophylaxis improves outcome and reduces the risk for bronchiolitis obliterans syndrome (BOS) after lung transplantation.

Authors:  Elfriede Ruttmann; Christian Geltner; Brigitte Bucher; Hanno Ulmer; Daniel Höfer; Herbert B Hangler; Severin Semsroth; Raimund Margreiter; Günther Laufer; Ludwig C Müller
Journal:  Transplantation       Date:  2006-05-27       Impact factor: 4.939

4.  Bile acid aspiration and the development of bronchiolitis obliterans after lung transplantation.

Authors:  Frank D'Ovidio; Marco Mura; Melanie Tsang; Thomas K Waddell; Michael A Hutcheon; Lianne G Singer; Denis Hadjiliadis; Cecilia Chaparro; Carlos Gutierrez; Andrew Pierre; Gail Darling; Mingyao Liu; Shaf Keshavjee
Journal:  J Thorac Cardiovasc Surg       Date:  2005-05       Impact factor: 5.209

5.  Lymphocytic bronchiolitis after lung transplantation is associated with daily changes in air pollution.

Authors:  S E Verleden; H Scheers; T S Nawrot; R Vos; F Fierens; R Geenens; J Yserbyt; S Wauters; E K Verbeken; B Nemery; L J Dupont; D E Van Raemdonck; G M Verleden; B M Vanaudenaerde
Journal:  Am J Transplant       Date:  2012-06-08       Impact factor: 8.086

6.  Cumulative exposure to gamma interferon-dependent chemokines CXCL9 and CXCL10 correlates with worse outcome after lung transplant.

Authors:  D C Neujahr; S D Perez; A Mohammed; O Ulukpo; E C Lawrence; F Fernandez; A Pickens; S D Force; M Song; C P Larsen; A D Kirk
Journal:  Am J Transplant       Date:  2011-12-07       Impact factor: 8.086

7.  The impact of traffic air pollution on bronchiolitis obliterans syndrome and mortality after lung transplantation.

Authors:  Tim S Nawrot; Robin Vos; Lotte Jacobs; Stijn E Verleden; Shana Wauters; Veerle Mertens; Christophe Dooms; Peter H Hoet; Dirk E Van Raemdonck; Christel Faes; Lieven J Dupont; Benoit Nemery; Geert M Verleden; Bart M Vanaudenaerde
Journal:  Thorax       Date:  2011-03-23       Impact factor: 9.139

Review 8.  Bronchiolitis obliterans syndrome: the Achilles' heel of lung transplantation.

Authors:  S Samuel Weigt; Ariss DerHovanessian; W Dean Wallace; Joseph P Lynch; John A Belperio
Journal:  Semin Respir Crit Care Med       Date:  2013-07-02       Impact factor: 3.119

9.  Interstitial inflammatory lesions of the pulmonary allograft: a retrospective analysis of 2697 transbronchial biopsies.

Authors:  Christopher M Burton; Martin Iversen; Jørn Carlsen; Claus B Andersen
Journal:  Transplantation       Date:  2008-09-27       Impact factor: 4.939

10.  Primary graft dysfunction and long-term pulmonary function after lung transplantation.

Authors:  Bryan A Whitson; Matthew E Prekker; Cynthia S Herrington; Timothy P M Whelan; David M Radosevich; Marshall I Hertz; Peter S Dahlberg
Journal:  J Heart Lung Transplant       Date:  2007-10       Impact factor: 10.247

View more
  29 in total

1.  Airway Epithelial Telomere Dysfunction Drives Remodeling Similar to Chronic Lung Allograft Dysfunction.

Authors:  Ram P Naikawadi; Gary Green; Kirk D Jones; Natalia Achtar-Zadeh; Julia E Mieleszko; Isabel Arnould; Jasleen Kukreja; John R Greenland; Paul J Wolters
Journal:  Am J Respir Cell Mol Biol       Date:  2020-10       Impact factor: 6.914

2.  Telomere length in patients with pulmonary fibrosis associated with chronic lung allograft dysfunction and post-lung transplantation survival.

Authors:  Chad A Newton; Julia Kozlitina; Jefferson R Lines; Vaidehi Kaza; Fernando Torres; Christine Kim Garcia
Journal:  J Heart Lung Transplant       Date:  2017-02-04       Impact factor: 10.247

3.  CCR4 expression on host T cells is a driver for alloreactive responses and lung rejection.

Authors:  Vyacheslav Palchevskiy; Ying Ying Xue; Rita Kern; Stephen S Weigt; Aric L Gregson; Sophie X Song; Michael C Fishbein; Cory M Hogaboam; David M Sayah; Joseph P Lynch; Michael P Keane; David G Brooks; John A Belperio
Journal:  JCI Insight       Date:  2019-05-14

Review 4.  How I treat bronchiolitis obliterans syndrome after hematopoietic stem cell transplantation.

Authors:  Kirsten M Williams
Journal:  Blood       Date:  2016-11-16       Impact factor: 22.113

5.  Update in lung transplantation 2013.

Authors:  Jamie L Todd; Jason D Christie; Scott M Palmer
Journal:  Am J Respir Crit Care Med       Date:  2014-07-01       Impact factor: 21.405

6.  Validation and Refinement of Chronic Lung Allograft Dysfunction Phenotypes in Bilateral and Single Lung Recipients.

Authors:  Ariss DerHovanessian; Jamie L Todd; Alice Zhang; Ning Li; Aradhna Mayalall; C Ashley Finlen Copeland; Michael Shino; Elizabeth N Pavlisko; W Dean Wallace; Aric Gregson; David J Ross; Rajan Saggar; Joseph P Lynch; John Belperio; Laurie D Snyder; Scott M Palmer; S Sam Weigt
Journal:  Ann Am Thorac Soc       Date:  2016-05

7.  Host-Pathogen Interactions and Chronic Lung Allograft Dysfunction.

Authors:  John Belperio; Scott M Palmer; S Sam Weigt
Journal:  Ann Am Thorac Soc       Date:  2017-09

8.  The histomorphological spectrum of restrictive chronic lung allograft dysfunction and implications for prognosis.

Authors:  Jan H von der Thüsen; Elly Vandermeulen; Robin Vos; Birgit Weynand; Erik K Verbeken; Stijn E Verleden
Journal:  Mod Pathol       Date:  2018-01-12       Impact factor: 7.842

Review 9.  Inflammasomes and IL-1 biology in the pathogenesis of allograft dysfunction.

Authors:  S Samuel Weigt; Vyacheslav Palchevskiy; John A Belperio
Journal:  J Clin Invest       Date:  2017-06-01       Impact factor: 14.808

10.  Graft Loss and CLAD-Onset Is Hastened by Viral Pneumonia After Lung Transplantation.

Authors:  Paul R Allyn; Erin L Duffy; Romney M Humphries; Patil Injean; S Samuel Weigt; Rajan Saggar; Michael Y Shino; Joseph P Lynch; Abbas Ardehali; Bernard Kubak; Chi-Hong Tseng; John A Belperio; David J Ross; Aric L Gregson
Journal:  Transplantation       Date:  2016-11       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.